News

AR-42 is a broad-spectrum deacetylation inhibitor of both histone and non-histone proteins, which help in regulation of gene expression, cell growth and survival. The compound has shown greater

The filing represents the fifth ANDA Acella has waiting approval from the FDA, the company said. Acella develops a range of specialty pharmaceutical and other products in the

APP worked with the FDA to expedite approval of the oncology drug due to nationwide shortage, the company said. The company began the process of scheduling production so

The company will follow the advice of the EMA’s Committee for Medicinal Products for Human Use (CHMP) in making changes to the product information details for its high

In a study of overweight individuals with elevated blood glucose levels, test subjects taking GlucAffect lowered their fasting blood glucose by an average of 30%, moving to healthy

The plant manufactures raw materials, including chemicals and intermediates used in pharmaceutical manufacturing, InPharma reported. The new facility will accommodate high-volume processes and back-end integration for starting materials

The contract provides Actelion with the exclusive commercialization rights to tesamorelin in Canada. As per the agreement, Actelion will be responsible for all ongoing regulatory and future commercialization

NineSigma has connected IAVI with some of the biomedical researchers, and helped it identify two scientists who will receive $875,000 to develop solutions for generating stable protein complexes

As per the agreement, Novartis will pay an upfront payment of $34m to Enanta and is even eligible to receive up to $406m if certain clinical, regulatory, and